Y mAbs Therapeutics (YMAB) Q1 2025 Earnings

4MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.21
-0.18
-0.15
-0.12

Details

Expected EPS
-0.11613
Actual EPS
-0.15
Surprise EPS
-0.03
Surprise Percent
+29.17%

Description

Y mAbs Therapeutics (YMAB) has reported earnings of -0.15 per share for Q1 2025.

0 Comments

Share your thoughts